OIG finds VA not fully following acquisition policy September 25, 2020 -- The Department of Veterans Affairs, Office of Inspector General (OIG) found the Veterans Health Administration did not consistently support its acquisition of robotic surgical systems as required by Veterans Affairs (VA) policy.
FDA revokes Va. facility's mammography accreditation September 25, 2020 -- The U.S. Food and Drug Administration (FDA) The U.S. Food and Drug Administration (FDA) has revoked the Mammography Quality Standards Act (MQSA) certificate for Allison Breast Center at Monument Radiology in Richmond, VA. The agency said any patient who was seen on or after June 17, 2018, may have a problem with the quality of their mammograms.
Serial chest x-ray for COVID-19 comparable to CT September 25, 2020 -- The sensitivity of serial chest x-rays for COVID-19 detection approaches the performance of chest CT, according to a study published on September 24 in Radiology: Cardiothoracic Imaging.
Telix files NDA for prostate cancer PET imaging agent September 24, 2020 -- Radiopharmaceutical company Telix Pharmaceuticals has submitted a new drug application (NDA) to the U.S. Food and Drug Administration for TLX591-CDx, its gallium-68-based radiopharmaceutical for PET imaging of prostate cancer.
IBA receives 1st payment from Chinese licensing deal September 24, 2020 -- Proton therapy developer Ion Beam Applications (IBA) has received the first payment of 20 million euros ($23.3 million U.S.) from its strategic licensing deal with CGN Nuclear Technology Development in China.
Guerbet revenues drop due to COVID-19 crisis September 24, 2020 -- Contrast developer Guerbet saw revenues fall 8.4% after currency adjustment in the first half of its financial year due to the impact of the COVID-19 pandemic on the company's sales.
EOS revenues jump as sales resume September 24, 2020 -- Orthopedic imaging technology developer EOS Imaging reported 63% growth in revenues in the first half of the company's financial year as system shipments resumed after being interrupted by the COVID-19 outbreak.
Kubtec touts study on specimen biopsy system September 23, 2020 -- Kubtec's 3D Mozart specimen biopsy system reduces the need for breast cancer patients to undergo reexcisions after initial surgeries by more than 50%, according to a recent study published in the Annals of Surgical Oncology.